Literature DB >> 8717428

Non-proline-dependent protein kinases phosphorylate several sites found in tau from Alzheimer disease brain.

T J Singh1, T Zaidi, I Grundke-Iqbal, K Iqbal.   

Abstract

Of 21 phosphorylation sites identified in PHF-tau 11 are on ser/thr-X motifs and are probably phosphorylated by non-proline-dependent protein kinases (non-PDPKs). The identities of the non-PDPKs and how they interact to hyperphosphorylate PHF-tau are still unclear. In a previous study we have shown that the rate of phosphorylation of human tau 39 by a PDPK (GSK-3) was increased several fold if tau were first prephosphorylated by non-PDPKs (Singh et al., FEBS Lett 358: 267-272, 1995). In this study we have examined how the specificity of a non-PDPK for different sites on human tau 39 is modulated when tau is prephosphorylated by other non-PDPKs (A-kinase, C-kinase, CK-1, CaM kinase II) as well as a PDPK (GSK-3). We found that the rate of phosphorylation of tau 39 by a non-PDPK can be stimulated if tau were first prephosphorylated by other non-PDPKs. Of the four non-PDPKs only CK-1 can phosphorylate sites (thr 231, ser 396, ser 404) known to be present in PHF-tau. Further, these sites were phosphorylated more rapidly and to a greater extent by CK-1 if tau 39 were first prephosphorylated by A-kinase, CaM kinase II or GSK-3. These results suggest that the site specificities of the non-PDPKs that participate in PHF-tau hyperphosphorylation can be modulated at the substrate level by the phosphorylation state of tau.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8717428     DOI: 10.1007/BF00226782

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  44 in total

1.  Microtubule-associated protein tau is phosphorylated by protein kinase C on its tubulin binding domain.

Authors:  I Correas; J Díaz-Nido; J Avila
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.157

2.  Application of synthetic phospho- and unphospho- peptides to identify phosphorylation sites in a subregion of the tau molecule, which is modified in Alzheimer's disease.

Authors:  W K Liu; W T Moore; R T Williams; F L Hall; S H Yen
Journal:  J Neurosci Res       Date:  1993-02-15       Impact factor: 4.164

3.  A protein kinase associated with paired helical filaments in Alzheimer disease.

Authors:  I J Vincent; P Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

4.  Comparison of the phosphorylation of microtubule-associated protein tau by non-proline dependent protein kinases.

Authors:  T J Singh; I Grundke-Iqbal; B McDonald; K Iqbal
Journal:  Mol Cell Biochem       Date:  1994-02-23       Impact factor: 3.396

5.  p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease [corrected].

Authors:  M Goedert; E S Cohen; R Jakes; P Cohen
Journal:  FEBS Lett       Date:  1992-11-02       Impact factor: 4.124

6.  Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.

Authors:  D P Hanger; K Hughes; J R Woodgett; J P Brion; B H Anderton
Journal:  Neurosci Lett       Date:  1992-11-23       Impact factor: 3.046

7.  Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau.

Authors:  E M Mandelkow; G Drewes; J Biernat; N Gustke; J Van Lint; J R Vandenheede; E Mandelkow
Journal:  FEBS Lett       Date:  1992-12-21       Impact factor: 4.124

8.  Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments.

Authors:  H K Paudel; J Lew; Z Ali; J H Wang
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

9.  Rapid Alzheimer-like phosphorylation of tau by the synergistic actions of non-proline-dependent protein kinases and GSK-3.

Authors:  T J Singh; N Haque; I Grundke-Iqbal; K Iqbal
Journal:  FEBS Lett       Date:  1995-01-30       Impact factor: 4.124

10.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

View more
  7 in total

1.  S100beta interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease.

Authors:  W H Yu; P E Fraser
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

2.  Potentiation of GSK-3-catalyzed Alzheimer-like phosphorylation of human tau by cdk5.

Authors:  A Sengupta; Q Wu; I Grundke-Iqbal; K Iqbal; T J Singh
Journal:  Mol Cell Biochem       Date:  1997-02       Impact factor: 3.396

3.  Protein kinase C and calcium/calmodulin-dependent protein kinase II phosphorylate three-repeat and four-repeat tau isoforms at different rates.

Authors:  T J Singh; I Grundke-Iqbal; W Q Wu; V Chauhan; M Novak; E Kontzekova; K Iqbal
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

4.  A transitory activation of protein kinase-A induces a sustained tau hyperphosphorylation at multiple sites in N2a cells-imply a new mechanism in Alzheimer pathology.

Authors:  Y Zhang; H-L Li; D-L Wang; S-J Liu; J-Z Wang
Journal:  J Neural Transm (Vienna)       Date:  2006-02-09       Impact factor: 3.575

Review 5.  Tau and neurodegenerative disease: the story so far.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Nat Rev Neurol       Date:  2015-12-04       Impact factor: 42.937

Review 6.  Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletion.

Authors:  Gjumrakch Aliev; Mark E Obrenovich; Shams Tabrez; Nasimudeen R Jabir; V Prakash Reddy; Yi Li; Geoffrey Burnstock; Ramon Cacabelos; Mohammad Amjad Kamal
Journal:  Oxid Med Cell Longev       Date:  2013-04-03       Impact factor: 6.543

7.  Hyperphosphorylation-induced tau oligomers.

Authors:  Khalid Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  Front Neurol       Date:  2013-08-15       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.